Of late, high-content active vitamins have become popular among Koreans as they are known to be effective against physical fatigue. The active vitamin market is growing at more than 30% annually, with a wide range of products putting on the market. Experts recommend closely examining products for their vitamin content and properties.
“Benfobel,” manufactured by Chong Kun Dang Pharm, is a multivitamin of nine B vitamins including active vitamin benfothiamine. It also contains ursodeoxycholic acid (UDCA), coenzyme Q10 (CoQ10), Vitamin C, D, E and zinc. Benfobel contains nutrient components necessary for maintaining our health. One pill can provide the nutrients that the body needs.
Benfothiamine is the main ingredient of Benfobel. It is the active vitamin B1 component that can relieve fatigue, eyestrain, neuralgia, and muscular pain. Its absorption into the body is higher than other vitamin B1 medicines and has a longer effect
Besides Benfothiamine, this product contains 100 mg each of vitamin B2, B6 and B12, and can help with fatigue, stomatitis, and dermatitis.
In addition, there are 30 mg of UDCA compounds and antioxidants that are used for liver improvement; coenzyme Q10 (CoQ10) that protects cells from damage and plays an important part in metabolism; inositol which is effective for control of cholesterol; zinc that is used for boosting the immune system; and Vitamin C, D, E, all nutrients that are necessary for our health management today. In just one pill, users can receive the full nutrients they need daily, and the smaller size has made swallowing easier.
|“Benfobel,” high-content active vitamin|
An official of Chong Kun Dang Pharm said, "These days, people are more likely to complain of chronic fatigue, immunology and decline in health due to excessive stress, irregular living patterns and poor eating habits. “Benfobel will enable people to recover from fatigue, as well as maintaining good health.”
Chong Kun Dang manufactures and distributes a range of pharmaceutical products worldwide. It offers prescription drugs; over-the-counter pharmaceutical products; health supplements; consumer health products, including health drinks, insecticides, hair dyes, and other products. The company was founded in 1941 and is headquartered in Seoul, Korea.
Dedicated to pharmaceuticals since its foundation, Chong Kun Dang has overcome many challenges, while continuing to grow and contribute to the development of Korea’s pharmaceutical industry.
In the days when Korea imported 100% of the ingredients required for medicines from abroad, the company has built Korea’s largest plants for chemical synthesis and fermentation, making it possible to produce pharmaceutical ingredients locally using its own technology. From there, the company has driven Korean Pharmaceutical Industry with this breakthrough on the path toward modernization.
Furthermore, we became the first Korean pharmaceutical firm to export products to the US market through the obtainment of the U.S. FDA approval.
Now, marking our 77th anniversary, we promise to put all efforts to lead continuous change and innovation, positioning Chong Kun Dang as a global pharmaceutical company with a competitive edge in the international market.
Since the foundation, Chong Kun Dang has been pursuing a disease-free society by developing excellent medicines. Cognizant of the importance of drug discovery,
Chong Kun Dang was the first in Korea to run its own research institute. It also invested a huge portion of its resources in nurturing and training research manpower.
hwi won email@example.com
<저작권자 © 코리아포스트, 무단 전재 및 재배포 금지>